Règlement ministériel du 15 mars 1976 relatif à la désignation des spécialités pharmaceutiques qui ne peuvent être librement vendues en pharmacie.

This preamble identifies the ministerial regulation and says the Minister of Public Health and the Environment makes it after considering cited legal bases and a medical board opinion.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction: Luxembourg
Instrument: Regulation
Citation: http://data.legilux.public.lu/eli/etat/leg/rmin/1976/03/15/n1/jo
Status: In force
Version: Undated source snapshot
Language: fr
Updated: 15 Mar 1976
Official source: View official record ↗

drug control medicine dispensing medicine sales pharmaceutical dispensing pharmaceutical regulation pharmaceutical sales pharmacies prescription medicines prescription renewal

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

This preamble identifies the ministerial regulation and says the Minister of Public Health and the Environment makes it after considering cited legal bases and a medical board opinion. Some pharmaceutical specialties may only be sold in pharmacies on a medical prescription, and only if they are authorized and marked with “S”, “RR”, or “R” on the Minister’s published lists. The renewal of dispensing a pharmaceutical specialty marked “RR” is only allowed if the prescriber has expressly noted it on the prescription. A marked pharmaceutical specialty may be renewed if the prescriber has not expressly forbidden it. Products marked with the sign “S” are additionally regulated by the referenced grand-ducal regulation.

Read the provisions Ask with citations

Search within this statute

Search all stored provisions in this version.

Legal text

Provisions of Règlement ministériel du 15 mars 1976 relatif à la désignation des spécialités pharmaceutiques qui ne peuvent être librement vendues en pharmacie.

Showing 6 of 6

Part preamble

Preamble

preamble
Preamble
Verify source ↗

AI-assisted research summary: This preamble identifies the ministerial regulation and says the Minister of Public Health and the Environment makes it after considering cited legal bases and a medical board opinion.

Le contenu de la version HTML du Journal officiel luxembourgeois est identique Ã la version PDF. RÃ¨glement ministÃ©riel du 15 mars 1976 relatif Ã la dÃ©signation des spÃ©cialitÃ©s pharmaceutiques qui ne peuvent Ãªtre librement vendues en pharmacie. Le Ministre de la SantÃ© Publique et de l'Environnemen,t Vu l'article 19 du IVe rÃ¨glement sur les devoirs spÃ©ciaux des pharmaciens et droguistes, annexÃ© Ã l'ordonnance royale grand-ducale du 12 octobre 1841, portant rÃ¨glement du service mÃ©dical; Vu la loi du 4 aoÃ»t 1975 portant rÃ©glementation de la mise sur le marchÃ© et de la publicitÃ© des spÃ©cialitÃ©s pharmaceutiques et des mÃ©dicaments prÃ©fabriquÃ©s; Vu l'avis du CollÃ¨ge mÃ©dical; ArrÃªte: â

1 er
Art. 1 er .
Verify source ↗

AI-assisted research summary: Some pharmaceutical specialties may only be sold in pharmacies on a medical prescription, and only if they are authorized and marked with “S”, “RR”, or “R” on the Minister’s published lists.

Art. 1 er . Ne peuvent Ãªtre vendues dans les pharmacies que sur ordonnance mÃ©dicale, les spÃ©cialitÃ©s pharmaceutiques pour lesquelles l'autorisation prÃ©vue par la loi du 4 aoÃ»t 1975 prÃ©citÃ©e a Ã©tÃ© accordÃ©e et qui, sur les listes publiÃ©es par le Ministre de la SantÃ© Publique en exÃ©cution de cette loi, sont prÃ©cÃ©dÃ©es d'un des signes Â«SÂ» ou Â«RRÂ» ou Â«RÂ». â
2
Art. 2.
Verify source ↗

AI-assisted research summary: The renewal of dispensing a pharmaceutical specialty marked “RR” is only allowed if the prescriber has expressly noted it on the prescription.

Art. 2. Le renouvellement de la dÃ©livrance d'une spÃ©cialitÃ© pharmaceutique prÃ©cÃ©dÃ©e du signe Â«RRÂ» n'est autorisÃ© que dans la mesure oÃ¹ le prescripteur en a fait mention expresse sur l'ordonnance. â
3
Art. 3.
Verify source ↗

AI-assisted research summary: A marked pharmaceutical specialty may be renewed if the prescriber has not expressly forbidden it.

Art. 3. Le renouvellement de la dÃ©livrance d'une spÃ©cialitÃ© pharmaceutique prÃ©cÃ©dÃ©e du signe Â«RÂ» est autorisÃ©, mÃªme sans mention apportÃ©e par le prescripteur, mais Ã condition que celui-ci ne l'ait pas dÃ©fendu expressÃ©ment. Toutefois, Ã moins d'une indication contraire du prescripteur, le renouvellement est limitÃ© pour une pÃ©riode de trois mois Ã dater du jour de la rÃ©daction de l'ordonnance et Ã pas plus de cinq fois pendant cette pÃ©riode. En aucun cas la quantitÃ© totale dÃ©livrÃ©e ne devra permettre de dÃ©passer la posologie autorisÃ©e par le prescripteur. â
4
Art. 4.
Verify source ↗

AI-assisted research summary: Products marked with the sign “S” are additionally regulated by the referenced grand-ducal regulation.

Art. 4. La dispensation des produits prÃ©cÃ©dÃ©s du signe Â«SÂ» est rÃ©glÃ©e en outre par le rÃ¨glement grand-ducal du 19 fÃ©vrier 1974 portant exÃ©cution de la loi du 19 fÃ©vrier 1973 sur la vente des substances mÃ©dicamenteuses et la lutte contre la toxicomanie. â
5
Art. 5.
Verify source ↗

AI-assisted research summary: This article repeals a 1963 ministerial order about pharmacy sales of certain pharmaceutical products.

Art. 5. L'arrÃªtÃ© ministÃ©riel du 7 septembre 1963 portant publication de laliste des spÃ©cialitÃ©s pharmaceutiques qui ne peuvent pas Ãªtre librement vendues en pharmacie est abrogÃ©. Luxembourg, le 15 mars 1976 Le Ministre de la SantÃ© Publique et de l'Environnement, Emile Krieps

Provision text is displayed from LexChat’s stored statute record. Use the official source links to verify amendments, commencement, and current legal force.

About this LexChat collection

Publisher and coverage

LexChat is published by Esheria. Coverage reflects the legislation currently mapped from identified source collections; it may be incomplete, delayed, or later corrected. The official source controls where it differs from this research page.

AI and research method

AI-generated material is explicitly labelled and published only through LexChat's quality controls. It is a research aid, not the source document.

Corrections and reporting

Report a source mismatch, factual issue, personal-data concern, or licensing question to support@esheria.co.ke. Include this page's URL and the supporting official source so the record can be reviewed, corrected, restricted, or withdrawn.

Legal-information disclaimer

LexChat provides legal information and research tools, not legal advice. Verify currency, status, citations, and jurisdiction with authoritative sources and a qualified professional where appropriate.